Beam the MinIon Up

NASA plans to test out Oxford Nanopore Technologies' MinIon to see whether it's possible to sequence DNA in space. If it is, the agency says that the approach can be applied to study how space affects organisms' DNA, track the health of the crew, and possibly identify DNA-based life from elsewhere in the universe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.